does my insurance cover semaglutide compounded semaglutide? My Insurance Won't Cover GLP-1

As a GLP-1 antagonist, initially used to treat type 2 diabetes, GLP-1 offers a unique approach to weight loss

This clinical trial studied the weight loss effects of tirzepatide (Mounjaro) in non-diabetic patients over 72 weeks

Loading Comments Join today to unlock all member benefits including full access to all CL Answers and over 1,400 product reviews

Periods of inconsistency correlate with reduced results

Retatrutide (research code LY-3437943) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a novel triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIP-R), and glucagon receptor (GCG-R)